Redhill Biopharma
RDHL
#11160
Rank
โ‚น0.23 B
Marketcap
โ‚น26.04
Share price
-13.08%
Change (1 day)
-71.77%
Change (1 year)

Earnings for Redhill Biopharma (RDHL)

Earnings in 2022: -โ‚น6.65 Billion

According to Redhill Biopharma's latest financial reports the company's current earnings are โ‚น35.74 Million. In 2022 the company made an earning of -โ‚น6.65 Billion, an increase over its 2021 earnings that were of -โ‚น9.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Redhill Biopharma from 2012 to 2022

Annual earnings

Year Earnings Change
2022-โ‚น6.65 Billion-26.68%
2021-โ‚น9.06 Billion28.32%
2020-โ‚น7.06 Billion80.06%
2019-โ‚น3.93 Billion8.97%
2018-โ‚น3.6 Billion-14.76%
2017-โ‚น4.23 Billion55.07%
2016-โ‚น2.73 Billion39.26%
2015-โ‚น1.96 Billion96.9%
2014-โ‚น1 Billion0.78%
2013-โ‚น0.99 Billion16.93%
2012-โ‚น0.85 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
โ‚น721.71 B 67,200.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น623.02 B 57,997.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น663.00 B 61,725.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น113.42 B 10,477.26%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น4.05 B 277.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel